查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1777370

全球血管內導管市場

Intravascular Catheters
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 384 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球血管內導管市場規模將達到 151 億美元

全球血管內導管市場規模預計在2024年為76億美元，到2030年將達到151億美元，2024年至2030年的複合年成長率為12.0%。短PIVC是本報告分析的細分市場之一，預計其複合年成長率為13.4%，到分析期結束時規模將達到109億美元。整合/封閉式PIVC細分市場在分析期間的複合年成長率預計為8.9%。

美國市場預計將達到 21 億美元，中國市場的複合年成長率將達到 16.4%

預計到2024年，美國血管內導管市場規模將達21億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到32億美元，在2024-2030年的分析期間內，複合年成長率為16.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為8.6%和10.8%。在歐洲，預計德國市場的複合年成長率約為9.5%。

全球血管內導管市場－主要趨勢與促進因素摘要

血管內導管將如何徹底改變醫療程序？

由於微創手術需求的不斷成長、導管技術的進步以及需要血管通路的慢性疾病的日益增多，血管內導管市場正在經歷顯著成長。血管內導管在各種醫療應用中都至關重要，包括給藥、輸液、血液透析機、介入心臟病學和重症患者監護。這些導管提供安全、有效率、精準的血管通路，進而減少與傳統外科手術相關的併發症。

隨著全球心血管疾病 (CVD)、癌症治療以及需要透析的末期腎功能衰竭(ESRD) 病例的增多，醫院、門診手術中心和居家醫療機構對血管內導管的應用也日益增多。此外，介入性心臟病學、神經內科和放射學的發展也擴大了專用引導管、球囊導管和微導管在血管成形術、支架置入術術和血栓切除術等精密手術中的應用。

抗菌塗層導管、生物可吸收導管和導管導航系統等技術進步改善了感染控制、病人安全和手術效率。微創治療的興起，加上導管相關門診病人手術的日益普及，預計將推動市場持續擴張。

影響血管內導管市場的主要趨勢有哪些？

血管內導管市場最顯著的趨勢之一是抗菌和肝素塗層導管的發展。導管相關性血流感染 (CLABSI) 和血栓症是長期使用導管的主要併發症，導致住院率和死亡率上升。為了應對這個問題，製造商正在推出採用銀離子、洛赫西定和抗菌塗層的導管，以降低感染風險並延長導管的使用壽命。

另一個關鍵趨勢是將智慧感測器和即時監測功能整合到導管中。配備壓力感測器、無線連接和微流體技術的智慧導管能夠持續監測血流動力學，早期發現阻塞並改善液體管理。這些創新非常有價值，尤其是在加護病房(ICU) 和介入性心臟病學領域，即時病患資料可以顯著改善治療效果。

周邊置入中央靜脈導管(PICC) 和中線導管的日益普及也正在再形成市場格局。 PICC 是長期靜脈治療中中央靜脈導管(CVC) 的替代方案，可減少反覆靜脈穿刺的需求。中線導管可提供中間血管通路，在門診病人和家庭醫療保健環境中越來越受歡迎，它能夠實現經濟高效的長期靜脈治療，且無需承擔中心靜脈導管感染的風險。

另一個新興趨勢是使用生物分解性和可生物吸收的導管。傳統的聚合物導管可能引起異物反應和血栓症，而生物分解性導管會隨著時間的推移而溶解，從而最大限度地減少長期併發症。這項創新在需要最大程度減少殘留異物的情況下尤其有益，例如臨時導管置入、神經血管介入和兒科應用。

此外，介入和診斷導管手術的興起推動了對微導管和可控導引導管的需求。這些專用器械廣泛應用於血管成形術、栓塞術、介入神經放射學和電生理手術，能夠在複雜的血管結構中精確導航。機器人輔助導管導航系統的日益普及，進一步提高了導管介入手術的準確性、效率和成功率。

哪些挑戰正在影響血管內導管市場？

儘管血管內導管技術取得了許多進展，但仍存在一些挑戰阻礙其廣泛應用和市場成長。主要問題之一是導管相關感染疾病和血栓症，這可能導致嚴重併發症、延長住院時間並增加醫療費用。雖然抗菌塗層和先進的導管材料有助於降低感染風險，但嚴格的無菌技術和定期的導管維護對於預防併發症至關重要。

另一個重大挑戰是先進導管設備和手術的高成本。藥物釋放型洗脫導管、生物可吸收導管和整合感測器的導管價格昂貴，導致低收入地區難以取得。此外，某些國家對先進導管治療的報銷有限，這可能會限制患者獲得尖端治療的機會。

監管障礙和嚴格的核准流程也給市場進入者帶來了挑戰。 FDA（美國食品藥物管理局）、EMA（歐洲藥品管理局）和PMDA（英國藥品和醫療設備管理局）等醫療設備監管機構對新型導管技術、塗層和材料提出了嚴格的臨床試驗要求。冗長的核准流程會延遲產品上市並增加開發成本。

材料的生物相容性和導管的耐用性也是重要的考量。由矽膠、聚氨酯和PTFE（聚四氟乙烯）製成的導管必須具備最佳的柔韌性、抗扭結性和動態穩定性，以防止血栓形成和血管創傷。如何在柔軟度和耐用性之間取得平衡，同時確保較低的血栓形成性，仍然是製造商面臨的技術挑戰。

此外，有些地區缺乏接受過高階導管插入術訓練的熟練醫療專業人員，這也是一個限制因素。介入性心臟科醫師、放射科醫師和血管外科醫師需要接受專門訓練才能執行複雜的導管插入術，而專業知識的缺乏會影響手術的成功率。

哪些因素推動了血管內導管市場的成長？

血管內導管市場的成長受到多種因素的推動，包括心血管疾病盛行率的上升、微創介入技術的興起以及導管技術的持續創新。其中一個主要促進因素是心血管疾病盛行率的上升，例如冠狀動脈疾病 (CAD)、中風和周邊動脈疾病(PAD)，這些疾病需要基於導管的介入治療，例如血管成形術、置入術和血栓切除術。

另一個關鍵促進因素是導管在腫瘤科、腎臟科和神經科的應用不斷擴展。基於導管的化療輸注、用於末期腎功能衰竭(ESRD) 的透析導管以及用於中風治療的神經血管導管正在推動市場成長。全球癌症和腎臟疾病負擔的日益加重，推動了對長期血管通路設備的需求。

門診和居家輸液治療的日益普及進一步推動了市場擴張。中央靜脈導管( PICC) 和中線導管廣泛用於長期抗生素化療和腸外營養治療，使患者能夠在院外接受治療。這一趨勢在慢性病管理和老年護理領域尤其重要，因為居家靜脈輸液治療可以減少住院次數和醫療成本。

機器人導管導航、即時壓力感測導管和3D影像輔助導管置入等技術進步正在提高微創血管手術的準確性和安全性。基於人工智慧的導管置入引導系統的引入有助於減少併發症、改善手術效果並縮短手術時間。

此外，政府為改善血管通路護理和導管治療基礎設施所採取的措施和醫療投資也支持了市場的成長。許多新興國家正在擴大其介入性心臟病學和透析中心，從而提升了高品質血管通路解決方案的採用率。

隨著導管塗層、生物分解性材料、智慧感測器和主導影像處理的不斷進步，血管內導管市場有望持續成長和創新。專注於感染控制、經濟高效的解決方案和法規遵循的公司將在滿足全球醫療保健提供者和患者不斷變化的需求方面獲得競爭優勢。

部分

產品（短 PIVC、整合/封閉式PIVC）、應用（腫瘤科、胃腸科、腎臟科、感染疾病、其他）、最終用途（醫院、診所、門診手術中心、居家醫療、其他）

受訪公司範例

  • AMECATH
  • AngioDynamics, Inc.
  • Angiplast Pvt. Ltd.
  • Argon Medical Devices, Inc.
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company（BD）
  • Boston Scientific Corporation
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Hindustan Syringes & Medical Devices Ltd.
  • ICU Medical, Inc.
  • Johnson & Johnson
  • McKesson Corporation
  • Medline Industries, Inc.
  • Medtronic PLC
  • Nipro Medical Corporation
  • PRODiMED
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Smiths Medical

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP31676

Global Intravascular Catheters Market to Reach US$15.1 Billion by 2030

The global market for Intravascular Catheters estimated at US$7.6 Billion in the year 2024, is expected to reach US$15.1 Billion by 2030, growing at a CAGR of 12.0% over the analysis period 2024-2030. Short PIVC, one of the segments analyzed in the report, is expected to record a 13.4% CAGR and reach US$10.9 Billion by the end of the analysis period. Growth in the Integrated / Closed PIVC segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 16.4% CAGR

The Intravascular Catheters market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 16.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.6% and 10.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Intravascular Catheters Market - Key Trends & Drivers Summarized

How Are Intravascular Catheters Revolutionizing Medical Procedures?

The intravascular catheters market is witnessing significant growth due to increasing demand for minimally invasive procedures, advancements in catheter technology, and rising prevalence of chronic diseases requiring vascular access. Intravascular catheters are essential for a wide range of medical applications, including drug administration, fluid infusion, hemodialysis, cardiovascular interventions, and critical care monitoring. These catheters provide safe, efficient, and precise access to blood vessels, reducing complications associated with traditional surgical interventions.

With the global rise in cardiovascular diseases (CVDs), cancer treatments, and end-stage renal disease (ESRD) requiring dialysis, intravascular catheter adoption is increasing across hospitals, ambulatory surgical centers, and home healthcare settings. Additionally, the growth of interventional cardiology, neurology, and radiology has expanded the use of specialized guiding catheters, balloon catheters, and microcatheters for precision-based procedures such as angioplasty, stent placement, and thrombectomy.

Technological advancements, such as antimicrobial-coated catheters, bioabsorbable catheters, and catheter navigation systems, are enhancing infection control, patient safety, and procedural efficiency. The shift toward minimally invasive treatments, coupled with the increasing use of catheter-based therapies in outpatient settings, is expected to drive continued market expansion.

What Are the Key Trends Shaping the Intravascular Catheters Market?

One of the most notable trends in the intravascular catheters market is the development of antimicrobial and heparin-coated catheters. Catheter-associated bloodstream infections (CLABSIs) and thrombosis are major complications in long-term catheter use, leading to increased hospitalizations and mortality rates. To address this, manufacturers are introducing catheters embedded with silver-ion, chlorhexidine, and antimicrobial coatings to reduce infection risks and improve catheter longevity.

Another key trend is the integration of smart sensors and real-time monitoring capabilities in catheters. Smart catheters equipped with pressure sensors, wireless connectivity, and microfluidic technology are enabling continuous hemodynamic monitoring, early detection of blockages, and improved fluid management. These innovations are particularly valuable in intensive care units (ICUs) and interventional cardiology, where real-time patient data can significantly improve outcomes.

The increasing adoption of peripherally inserted central catheters (PICCs) and midline catheters is also reshaping the market. PICCs offer an alternative to central venous catheters (CVCs) for long-term intravenous therapy, reducing the need for repeated venipunctures. Midline catheters, which provide intermediate vascular access, are gaining traction in outpatient settings and home healthcare, enabling cost-effective, extended IV therapy without the risks associated with central line infections.

Another emerging trend is the use of biodegradable and bioresorbable catheters. Traditional polymer-based catheters can cause foreign body reactions and thrombosis, whereas biodegradable catheters dissolve over time, minimizing long-term complications. This innovation is particularly beneficial in temporary catheter placements, neurovascular interventions, and pediatric applications where minimizing residual foreign material is critical.

Additionally, the rise in interventional and diagnostic catheterization procedures is driving demand for microcatheters and steerable guiding catheters. These specialized devices are widely used in angioplasty, embolization, neurointerventions, and electrophysiology procedures, allowing precise navigation through complex vascular structures. The increasing adoption of robot-assisted catheter navigation systems is further enhancing accuracy, efficiency, and procedural success rates in catheter-based interventions.

What Challenges Are Impacting the Intravascular Catheters Market?

Despite the numerous advancements in intravascular catheter technology, several challenges hinder widespread adoption and market growth. One of the primary concerns is catheter-related infections and thrombosis, which can lead to serious complications, extended hospital stays, and increased healthcare costs. While antimicrobial coatings and advanced catheter materials help reduce infection risks, strict aseptic techniques and regular catheter maintenance are essential to prevent complications.

Another major challenge is the high cost of advanced catheterization devices and procedures. Drug-eluting catheters, bioresorbable catheters, and sensor-integrated catheters come at a premium cost, making them less accessible in low-income regions. Additionally, reimbursement limitations for advanced catheter-based procedures in certain countries can restrict patient access to cutting-edge treatments.

Regulatory hurdles and stringent approval processes pose another challenge for market players. Medical device regulatory authorities such as the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and PMDA (Pharmaceuticals and Medical Devices Agency, Japan) impose strict clinical trial requirements for new catheter technologies, coatings, and materials. The time-consuming approval process can delay product launches and increase development costs.

Material biocompatibility and catheter durability are also key concerns. Catheters made from silicone, polyurethane, and PTFE (polytetrafluoroethylene) must exhibit optimal flexibility, kink resistance, and hemodynamic stability to prevent clot formation and vessel trauma. Balancing softness with durability while ensuring low thrombogenicity remains a technical challenge for manufacturers.

Additionally, the shortage of skilled healthcare professionals trained in advanced catheterization procedures is a limiting factor in some regions. Interventional cardiologists, radiologists, and vascular surgeons require specialized training to handle complex catheter-based interventions, and the lack of expertise can impact procedural success rates.

What Factors Are Driving the Growth of the Intravascular Catheters Market?

The growth in the intravascular catheters market is driven by several factors, including the rising incidence of cardiovascular diseases, the increasing use of minimally invasive interventions, and continuous innovations in catheter technology. One of the major drivers is the growing prevalence of cardiovascular disorders, such as coronary artery disease (CAD), stroke, and peripheral artery disease (PAD), which require catheter-based interventions such as angioplasty, stenting, and thrombectomy.

Another key driver is the expanding applications of catheters in oncology, nephrology, and neurology. Catheter-based chemotherapy infusion, dialysis catheters for end-stage renal disease (ESRD), and neurovascular catheters for stroke treatment are contributing to market growth. The rising global burden of cancer and kidney diseases is driving demand for long-term vascular access devices.

The increasing adoption of outpatient and home-based infusion therapies is further fueling market expansion. Peripherally inserted central catheters (PICCs) and midline catheters are being widely used for long-term antibiotic therapy, chemotherapy, and parenteral nutrition, allowing patients to receive treatment outside of hospital settings. This trend is particularly significant in chronic disease management and elderly patient care, where home-based IV therapy reduces hospital admissions and healthcare costs.

Technological advancements, such as robotic-assisted catheter navigation, real-time pressure-sensing catheters, and 3D imaging-assisted catheter placement, are enhancing the precision and safety of minimally invasive vascular procedures. The introduction of AI-driven catheter placement guidance systems is helping reduce complications, improve procedural outcomes, and shorten procedure times.

Additionally, government initiatives and healthcare investments in improving vascular access care and catheter-based treatment infrastructure are supporting market growth. Many developing countries are expanding interventional cardiology and dialysis centers, increasing the adoption of high-quality intravascular catheters and vascular access solutions.

With ongoing advancements in catheter coatings, biodegradable materials, smart sensors, and AI-driven imaging, the intravascular catheters market is poised for continuous growth and innovation. Companies that focus on infection control, cost-effective solutions, and regulatory compliance will gain a competitive advantage in meeting the evolving needs of healthcare providers and patients worldwide.

SCOPE OF STUDY:

The report analyzes the Intravascular Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Short PIVC, Integrated / Closed PIVC); Application (Oncology, Gastroenterology, Renal Disease, Infectious Diseases, Others); End-Use (Hospitals, Clinics, Ambulatory Surgery Centers, Homecare, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AMECATH
  • AngioDynamics, Inc.
  • Angiplast Pvt. Ltd.
  • Argon Medical Devices, Inc.
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company (BD)
  • Boston Scientific Corporation
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Hindustan Syringes & Medical Devices Ltd.
  • ICU Medical, Inc.
  • Johnson & Johnson
  • McKesson Corporation
  • Medline Industries, Inc.
  • Medtronic PLC
  • Nipro Medical Corporation
  • PRODiMED
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Smiths Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Intravascular Catheters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Number of Hospital Admissions and ICU Stays Drives Demand for Intravascular Catheters
    • Growth in Chronic Disease Management and Long-Term Infusions Expands Market Scope
    • Increase in Chemotherapy and Parenteral Nutrition Applications Spurs Central Venous Catheter Use
    • Advancements in Catheter Materials and Antimicrobial Coatings Reduce Infection Risks and Improve Outcomes
    • Adoption of Ultrasound-Guided Insertion Techniques Strengthens Procedural Safety and Precision
    • Rising Use of Midline and PICC Catheters in Outpatient and Home Infusion Settings Enhances Access
    • Expansion of Interventional Radiology and Cardiology Procedures Fuels Specialized Catheter Demand
    • Integration With Electronic Monitoring Systems Enables Real-Time Flow and Pressure Measurement
    • Surge in Sepsis and Critical Care Cases Highlights Importance of Reliable Vascular Access
    • AI-Based Vascular Access Planning and Patient Stratification Tools Improve Catheter Placement Strategies
    • Growing Preference for Single-Use, Sterile Devices Boosts Disposable Catheter Sales
    • Increased Demand for Short Peripheral Catheters in Emergency and Ambulatory Care Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intravascular Catheters Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intravascular Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Short PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Short PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Short PIVC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Integrated / Closed PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Integrated / Closed PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Integrated / Closed PIVC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Homecare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Renal Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Renal Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Renal Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intravascular Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Intravascular Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Intravascular Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Intravascular Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION